Csaba Poroszlai is confirmed CEO of the company by the Board of Directors of Egis. Balázs Vándor is appointed to the position of the Company’s Chief Financial Officer.
Hungarian-based Egis Pharmaceuticals PLC signed an exclusive distribution agreement with Mundipharma network for a pegfilgrastim biosimilar. Pursuant to the agreement, Egis gains the exclusive distribution rights related to the medicine used to reduce a common side effect of cancer treatment called neutropenia and the related life-threatening infections. Thus, Egis gets the opportunity to launch this pegfilgrastim biosimilar product in four Eastern European countries.
PharmaBoardroom is a site for senior professionals, providing global news, trends and reports relating to the pharmaceutical industry.
Today on 23rd March, we celebrate the Polish-Hungarian Friendship Day. We send our best wishes to our Hungarian colleagues and all lovers of Hungary. Poles and Hungarians have been bound by a close friendship for years. Let us wish that the historical slogan "Pole, Hungarian, two nephews" will never lose its validity. Minden jót!